ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Biogen Inc

Biogen Inc (1BIIB)

198.75
0.00
(0.00%)
Closed July 31 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
198.75
Bid
197.70
Ask
200.70
Volume
0.00
0.00 Day's Range 0.00
177.65 52 Week Range 244.60
Market Cap
Previous Close
198.75
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
29
Shares Outstanding
145,596,895
Dividend Yield
-
PE Ratio
27.03
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 198.75 €. Over the last year, Biogen shares have traded in a share price range of 177.65 € to 244.60 €.

Biogen currently has 145,596,895 shares outstanding. The market capitalization of Biogen is 28.94 € billion. Biogen has a price to earnings ratio (PE ratio) of 27.03.

1BIIB Latest News

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAIC

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The...

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease The collaboration aims to identify and develop accessible...

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo...

Biogen Completes Acquisition of Human Immunology Biosciences

Biogen Completes Acquisition of Human Immunology Biosciences CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology...

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China China is the Third Country to Launch LEQEMBI Following the United States and JapanTOKYO and CAMBRIDGE, Mass...

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union TOFIDENCE™ complements existing portfolio of immunology biosimilars commercialized by Biogen...

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease TOKYO and...

Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic...

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences Transaction to include felzartamab, a potential first-in-class...

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis Development of BIIB105, an investigational antisense oligonucleotide for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.452.29027277406194.3199.05194.328196.95DE
4-13.75-6.47058823529212.5220.7194.337209.93804348DE
12-4.75-2.33415233415203.5220.7194.329210.00542169DE
26-29.25-12.8289473684228229.2177.6533205.04222786DE
52-16.85-7.81539888683215.6244.6177.6529207.59340408DE
156-16.85-7.81539888683215.6244.6177.6529207.59340408DE
260-16.85-7.81539888683215.6244.6177.6529207.59340408DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1CYTHLumen Technologies Inc
2.351 €
(23.66%)
6.89k
WAMB26Ambromobiliare SpA
0.0319 €
(21.29%)
8.2k
1SRT3Sartorius AG
260.00 €
(16.18%)
21
WABTGAlfio Bardolla Training Group Spa
0.24 €
(14.29%)
450
1PLUGPlug Power Inc
2.314 €
(11.41%)
38.41k
WPRM28Prismi SpA
0.0112 €
(-30.00%)
11.9k
MNLMonnalisa SPA
0.70 €
(-14.63%)
54.45k
1CECCeconomy AG
2.794 €
(-11.64%)
555
1AENAAena S.M.E. S.A.
176.80 €
(-9.75%)
651
FDAFidia
0.318 €
(-9.14%)
668.68k
TITTelecom Italia SpA
0.2269 €
(-1.65%)
128.73M
ISPIntesa Sanpaolo Spa
3.7505 €
(-1.24%)
88.32M
ENELEnel Spa
6.597 €
(-0.50%)
20.5M
SPMSaipem Spa
2.203 €
(0.82%)
20.35M
RNRisanamento
0.0251 €
(-7.38%)
20.17M

Discussion

View Full Feed
BIOCHEMUP BIOCHEMUP 2 minutes ago
Back at 1cc
NXGT
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 minutes ago
https://x.com/moonequity/status/1817986556541682134?s=46
MONI
WarMachine WarMachine 2 minutes ago
As expected. Fast reply with nothing of value
MONI
Ecomike Ecomike 2 minutes ago
$IFUS The time is now. https://x.com/NotTheMoma2/status/1818701060682465771

$IFUS is the most significant game change event in the world of cattle in History.
A Game changer. And there is mega deal brewing, JV deal with India for world wide expansion already.

Thi
IFUS
BullNBear52 BullNBear52 2 minutes ago
https://futurism.com/the-byte/retired-astronaut-boeing-starliner
Monksdream Monksdream 2 minutes ago
LAES new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/31/tvdqfIMG_0196.gif
LAES
lakers17 lakers17 2 minutes ago
So much for charts and predictions. They don't work in the OTC and never have. Especially for long range predictions.
HIRU
newflow newflow 3 minutes ago
(iv) Additional Payment to REIT Series Holders from JPMC
As discussed in Sections V.B.3.b(viii) and VI.B.20 hereof, in addition to and separate from the distribution to be provided to holders of the REIT Series from the Debtors, pursuant to the Global Settlement Agreement and in exchange fo
JPM
BADALI BADALI 3 minutes ago
One big panic seller.
HIRU
monocle monocle 3 minutes ago
High volume today, looks like a bunch sold at 10 cents. Good luck to you sir.
NB
MR, MR, 3 minutes ago
Can someone post the link for the call?
MONI
ANTI-BAGHOLDER ANTI-BAGHOLDER 3 minutes ago
Huh? I am researching the people involved. Not the name Indexr.

These guys have never been involved in ptc tickers before, and seem to have plenty of contacts.

I look forward to being on the call today.
MONI
SCAMBUSTERKING SCAMBUSTERKING 3 minutes ago
Oh look, another "next week"

BAHAHAHAHAHAHAHAHAHA
HPIL
georgie18 georgie18 3 minutes ago
SGMO...84s clearing here...🥳on the Reversal...

georgie18

Member Level
Re: georgie18 post# 382237

Wednesday, July 31, 2024 10:46:17 AM

Post#
382238
of 382251
SGMO...76s clearing ...🥳...Reversal
SGMO
DrHigh DrHigh 3 minutes ago
and we do not know if he sold common to finance this acquisition as it is. Dumping shares is on the uptick. I suspect we are desperate for cash and angels are selling common to buy Cs for some good ol arbitrage.
NWBO
Ecomike Ecomike 3 minutes ago
$IFUS The time is now. https://x.com/NotTheMoma2/status/1818701060682465771

$IFUS is the most significant game change event in the world of cattle in History.
A Game changer. And there is mega deal brewing, JV deal with India for world wide expansion already.

Thi
IFUS
georgie18 georgie18 3 minutes ago
SGMO...84s clearing here...🥳on the Reversal...

georgie18

Member Level
Re: georgie18 post# 382237

Wednesday, July 31, 2024 10:46:17 AM

Post#
382238
of 382251
SGMO...76s clearing ...🥳...Reversal
SGMO
maumar maumar 4 minutes ago
The selling pressure at $56 is a bit stronger than I thought. Expected good news doesn't seem enough to cause the stock to break through.
HALO
georgie18 georgie18 4 minutes ago
SGMO...84s clearing here...🥳on the Reversal...

georgie18

Member Level
Re: georgie18 post# 382237

Wednesday, July 31, 2024 10:46:17 AM

Post#
382238
of 382251
SGMO...76s clearing ...🥳...Reversal
SGMO
Rais Rais 4 minutes ago
Thanks for cheap share add 3M
HIRU
surfer44 surfer44 4 minutes ago
Hello BSPC! I just gave this board a follow. GLTA
m$teamworkotc m$teamworkotc 4 minutes ago
$VXIT-0015 ON WATCH
UPDATES COMING
https://x.com/OfficialVXIT/status/1816835322921062643
VXIT
mugs57 mugs57 4 minutes ago
Latest MHRA News-at least they think they are doing a heck of a job!!!

Welcome
Welcome to the latest edition of MHRA News, our monthly newsletter for industry. We are committed to keeping you updated on what is going on at the MHRA and this newsletter is part of a broad effort
NWBO
TONY64 TONY64 4 minutes ago
Does anyone know where I can buy this? Tia.
KASUST
Monksdream Monksdream 5 minutes ago
GWAV new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/31/sybhbIMG_0195.gif
GWAV

Your Recent History

Delayed Upgrade Clock